BSP16 Datasheet DC Chemicals
Target Home > Products > Featured products
Cat.No DC72041
Name BSP16

Chemical Properties

CAS 2727249-47-8
Formula C16H18O5SE
MW 369.27
Storage 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO

Biological activity

Description CAS NO.:2727249-47-8
Product Name:BSP16
Synonyms:
EINECS:
Molecular Formula:C16H18O5Se
Molecular Weight:369.27
Target: IC50 for STING: 9.24 μM (ISG-THP1 cells); 5.71 μM (ISGRAW264.7 cells)[1]
In Vivo BSP16 (po, 50 mg/kg; iv, 5 mg/kg) has well lerated and excellent pharmacokinetic profile[1]. BSP16 (oral, 15 and 30 mg/kg, q3d; oral, 20 mg/kg, q5d) induces tumor regression and durable antitumor immunity[1]. Animal Model: MC38 (colon carcinoma) syngeneic tumor model[1] Dosage: 15, 30 mg/kg Administration: oral, q3d Result: Exhibited tolerated and excellent antitumor efficacy, experienced complete tumor regression (CR) after day 21. Resulted in robust induction of IFNB and IL6 (30 mg/kg). Animal Model: CT26 (colon carcinoma) tumor model[1] Dosage: 20 mg/kg Administration: oral, q5d Result: Exhibited tolerated and induced tumor regression in all treated mice within 30 days. Led to a substantial elevation of IFNB in the plasma in CT26 bearing mice. Animal Model: Rats[1] Dosage: 5 mg/kg, 50 mg/kg Administration: oral and i.v Result: compd. adm. Cmax(μg/mL) AUG0-∞(h*μg/mL) t1/2(h) Vss(L/kg) CL(L/h/kg) F(%) BSP16 po(50 mg/kg) 58.2 315.9 1.60 0.38 0.16 107 iv(5 mg/kg) 29.4 1.04 0.26 0.17
In Vitro BSP16 (0.1-100 μM) can selectively stimulate the STING pathway in ISG-THP1 and ISGRAW264.7 cells with EC50 values of 9.24 and 5.71 μM, respectively[1]. BSP16 (10, 25, 50 μM; 1, 3, 6 h) strongly activates STING signaling in human and mouse cells and binds STING as a homodimer[1]. BSP16 exhibits a promising absorption, distribution, metabolism, excretion and toxicity[1]. RT-PCR[1] Cell Line: ISG-THP1 cells Concentration: 10, 25, 50 μM Incubation Time: 1, 3, 6 h Result: Robustly induced mRNA expression of target genes IFNβ, CXCL10, and IL6 in response to STING activation, in a time and concentration-dependent manner in ISGTHP1 cells. Western Blot Analysis[1] Cell Line: ISG-THP1 cells Concentration: 10, 25, 50 μM Incubation Time: 1, 3, 6 h Result: Rapidly increased the phosphorylation of TBK1 and IRF3 in a concentration-dependent manner.
Kinase Assay
Cell Assay
Animal Administration

References

[1]. Xi Feng, et al. Discovery of Selenium-Containing STING Agonists as Orally Available Antitumor Agents. J Med Chem. 2022 Sep 7.
Return Policy
If you are in any way unsatisfied with your purchase, you may return any item(s) within 365 days of its original purchase date.
Please provide your Order Number in the email. We strive to reply to all email inquiries within one business day.
Tel: +86-21-58447131
Fax: +86-21-61642470

Email:
sales@dcchemicals.com
order@dcchemicals.com

Website:
www.dcchemicals.com